Management of early ovarian cancer

ONCOLOGY

Volumn 18, Issue 3, 2004, Pages 346-356

  Sonoda, Yukio ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65449185885     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Jemal A, Murray T, Samuels A, et al: Cancer statistics, 2003. CA Cancer J Clin 53:5-26, 2003.
2. Heintz AP, Odicino F, Maisonneuve P, et al: Carcinoma of the ovary. J Epidemiol Biostat 6:107-138, 2001.
3. Bhavana Pothuri, Mario Leitao, Richard R Barakat, et al: Genetic analysis of ovarian carcinoma histogenesis (abstract 7). Paper presented at the 32nd Annual Meeting of the Society of Gynecologic Oncologists, March 2-7, 2001, Miami Beach.
4. Leitao M, Pothuri B, Viale A, et al: Gene expression profiling of ovarian cystic epithelium, reveals a quasi-neoplastic phenotype (abstract 83). Paper presented at the 34th Annual Meeting of the Society of Gynecologic Oncologists, Jan 31-Feb 4, 2003, New Orleans.
5. McGowan L, Lesher LP, Norris HJ, et al: Misstaging of ovarian cancer. Obstet Gynecol 65:568-572, 1985.
6. Trimbos JB, Schueler JA, van Lent M, et al: Reasons for incomplete surgical staging in early ovarian carcinoma. Gynecol Oncol 37:374-377, 1990.
7. Munoz KA, Harlan LC, Trimble EL: Patterns of care for women with ovarian cancer in the United States. J Clin Oncol 15:3408-3415, 1997.
8. Guidelines for referral to a gynecologic oncologist: Rationale and benefits. The Society of Gynecologic Oncologists. Gynecol Oncol 78(3 pt 2):S1-S3, 2000.
9. Young RC, Decker DG, Wharton JT, et al: Staging laparotomy in early ovarian cancer. JAMA 250:3072-3076, 1983.
10. Reich H, McGlynn F, Wilkie W: Laparoscopic management of stage I ovarian cancer. A case report. J Reprod Med 35:601-605 (incl discussion), 1990.
11. Querleu D, Leblanc E: Laparoscopic infrarenal paraaortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube. Cancer 73:1467-1471, 1994.
12. Childers JM, Lang J, Surwit EA, et al: Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol 59:25-33, 1995.
13. Pomel C, Provencher D, Dauplat J, et al: Laparoscopic staging of early ovarian cancer. Gynecol Oncol 58:301-306, 1995.
14. Leblanc E, Querleu D, Narducci F, et al: Surgical staging of early invasive epithelial ovarian tumors. Semin Surg Oncol 19:36-41, 2000.
15. Schilder RJ, Boente MP, Corn BW, et al: The management of early ovarian cancer. Oncology 9:171-182, 1995.
16. Krivak TC, Sundborg M, Rose GS, et al: Hand assisted laparoscopic surgical staging of ovarian cancer. Presented at the 33rd Annual Meeting of the Society of Gynecologic Oncologists, March 16-20, 2002, Miami.
17. Scully RE: Recent progress in ovarian cancer. Hum Pathol 1:73-98, 1970.
18. Schilder JM, Thompson AM, DePriest PD, et al: Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 87:1-7, 2002.
19. Brown C, Dharmendra B, Barakat RR, et al: Preserving fertility in patients with epithelial ovarian cancer: The role of conservative surgery in treatment of early-stage disease (abstract 38). Paper presented at the 31st Annual Meeting of the Society of Gynecologic Oncologists, Feb 5-9, 2000, San Diego.
20. Morrow CP, Curtin JP: Tumors of the ovary: Neoplasms derived from celomic epithelium in Synopsis of Gynecologic Oncology, 5th ed, pp 233-280. Philadelphia, Churchill Livingstone, 1998.
21. Walton L, Ellenberg SS, Major F Jr, et al: Results of second-look laparotomy in patients with early-stage ovarian carcinoma. Obstet Gynecol 70:770-773, 1987.
22. Rubin SC, Jones WB, Curtin JP, et al: Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging. Obstet Gynecol 82:139-142, 1993.
23. Dembo AJ, Davy M, Stenwig AE, et al: Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 75:263-273, 1990.
24. Ahmed FY, Wiltshaw E, A'hern RP, et al: Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 14:2968-2975, 1996.
25. Vergote I, De Brabanter J, Fyles A, et al: Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357:176-182, 2001.
26. Monga M, Carmichael JA, Shelley WE, et al: Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging. Gynecol Oncol 43:195-197, 1991.
27. Young RC, Walton LA, Ellenberg SS, et al: Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 322:1021-1027, 1990.
28. Sevelda P, Vavra N, Schemper M, et al: Prognostic factors for survival in stage I epithelial ovarian carcinoma. Cancer 65:2349-2352, 1990.
29. Vergote IB, Kaern J, Abeler VM, et al: Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse. Am J Obstet Gynecol 169:40-52, 1993.
30. Rubin SC, Wong GY, Curtin JP, et al: Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging. Obstet Gynecol 82:143-147, 1993.
31. Zanetta G, Rota S, Chiari S, et al: The accuracy of staging: An important prognostic determinator in stage I ovarian carcinoma: A multivariate analysis. Ann Oncol 9:1097-1101, 1998.
32. NIH consensus conference: Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 273:491-497, 1995.
33. Thigpen JT: Limited-stage ovarian carcinoma. Semin Oncol 26(6 suppl 18):29-33, 1999.
34. Hernandez E, Bhagavan BS, Parmley TH, et al: Interobserver variability in the interpretation of epithelial ovarian cancer. Gynecol Oncol 17:117-123, 1984.
35. Brugghe J, Baak JP, Wiltshaw E, et al: Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment. Gynecol Oncol 68:47-53, 1998.
36. Schueler JA, Trimbos JB, van den Burg M, et al: DNA index reflects the biological behavior of ovarian carcinoma stage I-IIa. Gynecol Oncol 62:59-66, 1996.
37. Kohler NF, Kerns BJ, Humphrey PA, et al: Mutation and overexpression of p53 in early-stage epithelial cancer. Obstet Gynecol 81:643-650, 1993.
38. Leitao MM, Boyd J, Hummer A, et al: Clinicopathologic analysis of early stage sporadic ovarian carcinoma treated at a single institution (abstract 895). Paper presented at the 2003 Annual Meeting of the United States and Canadian Academy of Pathology, March 22-28, 2003, Washington, DC.
39. Paley PJ, Staskus KA, Gebhard K, et al: Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80:98-106, 1997.
40. Trimbos JB, Schueler JA, van der Burg M, et al: Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancer. Cancer 67:597-602, 1991.
41. Hreshchyshyn MM, Park RC, Blessing JA, et al: The role of adjuvant therapy in stage I ovarian cancer. Am J Obstet Gynecol 138:139-145, 1980.
42. Piver MS, Malfetano J, Baker TR, et al: Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: A preliminary report. Gynecol Oncol 35:69-72, 1989.
43. Dottino PR, Plaxe SC, Cohen CJ: A phase II trial of adjuvant cisplatin and doxorubicin in stage I epithelial ovarian cancer. Gynecol Oncol 43:203-205, 1991.
44. Bolis G, Colombo N, Pecorelli S, et al: Adjuvant treatment for early epithelial ovarian cancer: Results of two randomized clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). Ann Oncol 6:887-893, 1995.
45. Trope C, Kaern J, Hogberg T, et al: Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. Ann Oncol 11:281-288, 2000.
46. Trimbos JB, Vergote I, Bolis G, et al: Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95:113-125, 2003.
47. Colombo N, Guthrie D, Chiari S, et al: International Collaborative Ovarian Neoplasm Trial 1: A randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 95:125-132, 2003.
48. Trimbos JB, Parmar M, Vergote I, et al: International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant Chemotherapy in Ovarian Neoplasm Trial: Two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 95:105-112, 2003.
49. Bell J, Brady M, Lage J, et al: A randomized. phase III trial of three versus six cycles of carboplatin and paclitaxel as adjuvant treatment in early stage ovarian epithelial carcinoma: A GOG study (abstract 1). Paper presented at the 34th Annual Meeting of the Society of Gynecologic Oncologists, Jan 31-Feb 4, 2003, New Orleans.
50. Malmstrom H, Larsson D, Simonsen E: Phase I study of intraperitoneal carboplatin as adjuvant therapy in early ovarian cancer. Gynecol Oncol 39:289-294, 1990.
51. Malmstrom. H, Simonsen E, Westberg R: A phase II study of intraperitoneal carboplatin as adjuvant treatment in early-stage ovarian cancer patients. Gynecol Oncol 52:20-25, 1994.
52. Young RC, Brady MF, Nieberg RM, et al: Randomized clinical trial of adjuvant treatment of women with early (FIGO stage I-IIA high risk) ovarian cancer - GOG#95 (abstract 1376). Proc Am Soc Clin Oncol 18:357a, 1999.
53. Dembo, AJ, Bush RS, Beale FA, et al: The Princess Margaret Hospital study of ovarian cancer: Stages I, II, and asymptomatic III presentations. Cancer Treat Rep 63:249-254, 1979.
54. Klaassen D, Shelley W, Starreveld A, et al: Early stage ovarian cancer: A randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: A National Cancer Institute of Canada Clinical Trials Group report. J Clin Oncol 6:1254-1263, 1988.
55. Smith JP, Rutledge IN, Delclos L: Post-operative treatment of early cancer of the ovary: A random trial between postoperative irradiation and chemotherapy. Natl Cancer Inst Monogr 42:149-153, 1975.
56. Sell A, Bertelsen K, Andersen JE, et al: Randomized study of whole-abdomen irradiation vs pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 37:367-373, 1990.
57. Chiara S, Conte P, Franzone P, et al: Fligh-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide, vs whole abdominal radiotherapy. Am J Clin Oncol 17:72-76, 1994.
58. Dembo AJ: Radiotherapeutic management of ovarian cancer. Semin Oncol 11:238-250, 1994.
59. Vergote JIB, Winderen M, De Vos LN, et al: Intraperitoneal radioactive phosphorus therapy in ovarian carcinoma. Analysis of 313 patients treated primarily or at second-look laparotomy. Cancer 71:2250-2260, 1993.
60. Vergote IB, Vergote-De Vos LN, Abeler VM, et al: Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer. Cancer 69:741-749, 1992.